Sabina Berretta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sabina Berretta has a total of 323 co-authors. Here are the top co-authors by number of shared publications:
- Harry Pantazopoulos
Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS, USA
18 shared publications - Steven A. McCarroll
Harvard Medical School; Broad Institute; HHMI
9 shared publications - Jonathan Vogelgsang
Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, Goettingen, Germany
8 shared publications - Torsten Klengel
Division of Depression and Anxiety; McLean Hospital, Belmont, US
7 shared publications Michael Chatigny
McLean Hospital
6 shared publicationsPeter Durning
Translational Neuroscience Laboratory, McLean Hospital, Belmont, MA 02478, USA
6 shared publications
Latest Publications
- Open Access
- 5 August 2026
- Published by Springer Nature in Nature
- Vol. 657 (8131) , 455-468
Amygdala astrocyte primary cilium mechanisms contribute to stress behaviours
Understanding how adverse life events trigger stress-related behavioural changes remains an unresolved challenge. The amygdala is integral to emotion and stress responses 1 and comprises astrocytes, neurons and other cells. Here we show that amygdala astrocytes contribute to stress-related behaviours through signalling mechanisms related to their primary cilia 2 . Amygdala astrocytes are altered during stress at the protein and gene expression level, display reduced expression of molecules related to primary cilia 3,4 and have morphologically short primary cilia 5,6 . G protein-coupled receptors (GPCRs) are central to astrocyte 7 and primary cilia 2,8,9 function. Therefore, we speculated that GPCR signalling activation might be beneficial in stress-related behavioural disorders. We identified amygdala astrocyte GPCRs as regulators of responses following stress. Chemogenetics and targeting of native sphingosine-1-phosphate receptor 1 (S1PR1) GPCRs led to the restoration of astrocyte primary cilia length, corrected molecular alterations and improved stress-related behaviours. Cilium-related genes were abundantly expressed in human amygdala astrocytes, with many displaying disrupted expression in stress-related brain disorders. S1PR1 was also highly expressed in amygdala astrocytes from human tissue. Selective genetic disruption of amygdala astrocyte primary cilia in mice altered some stress-related behaviours and gene expression of astrocytes and parenchymal cells. These data confirm that astrocytic cilia have important roles in this brain nucleus. In summary, amygdala astrocytes and their primary cilia are disrupted during stress, and their restoration is accompanied by stress-related molecular and behavioural improvements. Astrocyte primary cilia-related mechanisms may therefore provide new treatment strategies for stress-related and other brain disorders.
- 5 August 2026
- Published by Springer Nature in Nature
- Vol. 657 (8131) , 455-468
Open AccessAmygdala astrocyte primary cilium mechanisms contribute to stress behaviours
Understanding how adverse life events trigger stress-related behavioural changes remains an unresolved challenge. The amygdala is integral to emotion and stress responses 1 and comprises astrocytes, neurons and other cells. Here we show that amygdala astrocytes contribute to stress-related behaviours through signalling mechanisms related to their primary cilia 2 . Amygdala astrocytes are altered during stress at the protein and gene expression level, display reduced expression of molecules related to primary cilia 3,4 and have morphologically short primary cilia 5,6 . G protein-coupled receptors (GPCRs) are central to astrocyte 7 and primary cilia 2,8,9 function. Therefore, we speculated that GPCR signalling activation might be beneficial in stress-related behavioural disorders. We identified amygdala astrocyte GPCRs as regulators of responses following stress. Chemogenetics and targeting of native sphingosine-1-phosphate receptor 1 (S1PR1) GPCRs led to the restoration of astrocyte primary cilia length, corrected molecular alterations and improved stress-related behaviours. Cilium-related genes were abundantly expressed in human amygdala astrocytes, with many displaying disrupted expression in stress-related brain disorders. S1PR1 was also highly expressed in amygdala astrocytes from human tissue. Selective genetic disruption of amygdala astrocyte primary cilia in mice altered some stress-related behaviours and gene expression of astrocytes and parenchymal cells. These data confirm that astrocytic cilia have important roles in this brain nucleus. In summary, amygdala astrocytes and their primary cilia are disrupted during stress, and their restoration is accompanied by stress-related molecular and behavioural improvements. Astrocyte primary cilia-related mechanisms may therefore provide new treatment strategies for stress-related and other brain disorders.
- Open Access
Somatic DNA-repeat expansions initiate distinct yet analogous changes in Huntington’s disease cortical and striatal neurons
Huntington’s disease (HD) affects the neocortex and striatum with different timing, severity, and gene-expression changes. These pathologies have long been proposed to involve different pathogenic mechanisms, with one brain area’s degeneration leading to the other’s. Striatal neurons degenerate in HD as their huntingtin ( HTT ) CAG-repeat tracts expand somatically beyond 150 CAGs. Here we find that cortical pyramidal neurons in HD undergo biological changes analogous to those in striatal neurons – the same sequence of pathological phases, with toxicity also commencing at ∼150 CAGs yet then changing their gene expression in distinct ways. Pyramidal neurons’ precise molecular identities, rather than their areal or laminar locations, appeared to determine the extent of this somatic DNA-repeat expansion, which varied up to 20-fold among pyramidal neuron subtypes. Cortical and striatal neurons also shared a key pathological feature: nuclear inclusions of aggregated HTT protein in those nuclei with expansions well beyond 150 CAGs.
Open AccessSomatic DNA-repeat expansions initiate distinct yet analogous changes in Huntington’s disease cortical and striatal neurons
Huntington’s disease (HD) affects the neocortex and striatum with different timing, severity, and gene-expression changes. These pathologies have long been proposed to involve different pathogenic mechanisms, with one brain area’s degeneration leading to the other’s. Striatal neurons degenerate in HD as their huntingtin ( HTT ) CAG-repeat tracts expand somatically beyond 150 CAGs. Here we find that cortical pyramidal neurons in HD undergo biological changes analogous to those in striatal neurons – the same sequence of pathological phases, with toxicity also commencing at ∼150 CAGs yet then changing their gene expression in distinct ways. Pyramidal neurons’ precise molecular identities, rather than their areal or laminar locations, appeared to determine the extent of this somatic DNA-repeat expansion, which varied up to 20-fold among pyramidal neuron subtypes. Cortical and striatal neurons also shared a key pathological feature: nuclear inclusions of aggregated HTT protein in those nuclei with expansions well beyond 150 CAGs.
- Open Access
- 4 October 2025
- Published by Springer Nature
- p. 155-191
Metabolic Abnormalities in Psychiatric Disorders A Transdiagnostic, Whole-Body Approach
- 4 October 2025
- Published by Springer Nature
- p. 155-191
Open AccessMetabolic Abnormalities in Psychiatric Disorders A Transdiagnostic, Whole-Body Approach
- Open Access
Genetic and structural evidence links Ca 2+ dysregulation and ATP2B2 to neuropsychiatric illness
Neuropsychiatric disorders are highly heritable, but the molecular mechanisms linking risk variants to disease remain unclear 1 . Linking genetics to biological mechanisms requires integrating evidence across scales, from sequence variation to gene regulation to protein function. Here we integrate genetic, transcriptomic, and structural evidence to identify dysregulation of neuronal Ca 2+ dynamics as a contributing mechanism. We analyzed single-nucleus neuronal RNA-seq data together with genome-wide association study (GWAS) heritability in a new way to identify gene expression programs enriched for psychiatric risk; genes encoding Ca 2+ flux pathway genes were implicated by this analysis, a result that was then confirmed by concentrations of rare coding variants in these same genes in persons with psychiatric disorders. A critical gene in this biology, ATP2B2 , encodes a Ca 2+ -extruding ATPase pump 2 linked to neuropsychiatric disorders primarily through missense variants. To recognize specific molecular functions affected by these missense variants, we developed a 3D-neighborhood-based method that maps missense variants onto AlphaFold3-predicted protein structures and tests clustering of protein-altering variants in three-dimensional space. This approach revealed clustering of these missense changes in the Ca 2+ pore and ATP:Mg 2+ coordination site of ATP2B2. To validate the structural predictions arising from the genetic analysis, we determined the structure of human Ca 2+ -bound ATP2B2 at 2.64 Å resolution by cryogenic electron microscopy. The structure replicated the 3D mutational hotspots identified by the genetic analysis, supporting the observation that neuropsychiatric variants cluster near specific catalytic sites of ATP2B2. In vitro experiments revealed that missense variants prioritized by the structural clustering analysis impaired ATP2B2-mediated Ca 2+ extrusion in cellular and biochemical assays. Together, these findings suggest that precise regulation of Ca 2+ dynamics is a contributing mechanism in neuropsychiatric disorders and establish a structure-based framework for predicting the mechanistic impact of missense variants.
Open AccessGenetic and structural evidence links Ca 2+ dysregulation and ATP2B2 to neuropsychiatric illness
Neuropsychiatric disorders are highly heritable, but the molecular mechanisms linking risk variants to disease remain unclear 1 . Linking genetics to biological mechanisms requires integrating evidence across scales, from sequence variation to gene regulation to protein function. Here we integrate genetic, transcriptomic, and structural evidence to identify dysregulation of neuronal Ca 2+ dynamics as a contributing mechanism. We analyzed single-nucleus neuronal RNA-seq data together with genome-wide association study (GWAS) heritability in a new way to identify gene expression programs enriched for psychiatric risk; genes encoding Ca 2+ flux pathway genes were implicated by this analysis, a result that was then confirmed by concentrations of rare coding variants in these same genes in persons with psychiatric disorders. A critical gene in this biology, ATP2B2 , encodes a Ca 2+ -extruding ATPase pump 2 linked to neuropsychiatric disorders primarily through missense variants. To recognize specific molecular functions affected by these missense variants, we developed a 3D-neighborhood-based method that maps missense variants onto AlphaFold3-predicted protein structures and tests clustering of protein-altering variants in three-dimensional space. This approach revealed clustering of these missense changes in the Ca 2+ pore and ATP:Mg 2+ coordination site of ATP2B2. To validate the structural predictions arising from the genetic analysis, we determined the structure of human Ca 2+ -bound ATP2B2 at 2.64 Å resolution by cryogenic electron microscopy. The structure replicated the 3D mutational hotspots identified by the genetic analysis, supporting the observation that neuropsychiatric variants cluster near specific catalytic sites of ATP2B2. In vitro experiments revealed that missense variants prioritized by the structural clustering analysis impaired ATP2B2-mediated Ca 2+ extrusion in cellular and biochemical assays. Together, these findings suggest that precise regulation of Ca 2+ dynamics is a contributing mechanism in neuropsychiatric disorders and establish a structure-based framework for predicting the mechanistic impact of missense variants.
- Top Cited PapersOpen Access
Long somatic DNA-repeat expansion drives neurodegeneration in Huntington’s disease
Top Cited PapersOpen AccessLong somatic DNA-repeat expansion drives neurodegeneration in Huntington’s disease
- Open Access
- 20 December 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (52)
SKA2 enhances stress-related glucocorticoid receptor signaling through FKBP4–FKBP5 interactions in neurons
Genes involved in regulating the hypothalamic–pituitary–adrenal (HPA) axis, including the glucocorticoid receptor (GR), are linked to various stress-related psychopathologies including bipolar disorder as well as other mood and trauma-related disorders. The protein product of the cell cycle gene, SKA2, is a GR interaction partner in peripheral cells. However, the precise roles of SKA2 in stress and GR signaling in the brain, specifically in nonreplicating postmitotic neurons, and its involvement in HPA axis regulation remain unclear. Here, we demonstrate, using diverse in vitro cell assays, a mechanism by which SKA2 promotes GR signaling through enhancing GR–FKBP4 interaction leading to dissociation of FK506-bindingprotein 51 (FKBP5) from the complex. FKBP4 and FKBP5 are cochaperones known to regulate GR function in opposite directions. Notably in mice, SKA2 in Crh + neurons of the paraventricular nucleus of the hypothalamus is crucial for HPA axis responsiveness and for maintaining the negative feedback loop underlying allostasis. Moreover, we show that SKA2 expression is increased in postmortem human hippocampus and amygdala from individuals with BD. Our study highlights a critical role of SKA2 in HPA axis function, adds to the understanding of the molecular basis of stress-related psychiatric disorders, and points to potential targets for intervention.
- 20 December 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (52)
Open AccessSKA2 enhances stress-related glucocorticoid receptor signaling through FKBP4–FKBP5 interactions in neurons
Genes involved in regulating the hypothalamic–pituitary–adrenal (HPA) axis, including the glucocorticoid receptor (GR), are linked to various stress-related psychopathologies including bipolar disorder as well as other mood and trauma-related disorders. The protein product of the cell cycle gene, SKA2, is a GR interaction partner in peripheral cells. However, the precise roles of SKA2 in stress and GR signaling in the brain, specifically in nonreplicating postmitotic neurons, and its involvement in HPA axis regulation remain unclear. Here, we demonstrate, using diverse in vitro cell assays, a mechanism by which SKA2 promotes GR signaling through enhancing GR–FKBP4 interaction leading to dissociation of FK506-bindingprotein 51 (FKBP5) from the complex. FKBP4 and FKBP5 are cochaperones known to regulate GR function in opposite directions. Notably in mice, SKA2 in Crh + neurons of the paraventricular nucleus of the hypothalamus is crucial for HPA axis responsiveness and for maintaining the negative feedback loop underlying allostasis. Moreover, we show that SKA2 expression is increased in postmortem human hippocampus and amygdala from individuals with BD. Our study highlights a critical role of SKA2 in HPA axis function, adds to the understanding of the molecular basis of stress-related psychiatric disorders, and points to potential targets for intervention.
- Open Access
The NeuroBioBank Whole-Genome Catalog: Sequencing from human brain donors with central nervous system disorders
Central nervous system diseases are a prevailing cause of morbidity and mortality worldwide, and are influenced by environmental and biological factors including genetic risk. Here we generated genome-wide genetic data on a large cohort of brain tissue donors with in-depth clinical and neuropathological phenotyping, allowing for broad investigations into the risk and mechanisms of these neurological, neurodevelopmental, and psychiatric conditions. This resource consists of 9,663 donors with array-based genotyping and 9,543 donors with whole-genome sequencing completed. The clinical diagnoses of these donors include 148 central nervous system diseases clustered in 15 broad categories by ICD-10 coding. These donors were collected by six repositories comprising the NIH NeuroBioBank, with an average participant age of 60 years. While primarily older individuals of European descent, the cohort also contains younger donors and individuals from non-European backgrounds. Variants detected by Whole-Genome Sequencing (WGS) were called genome-wide and annotated to describe their functional impact, resulting in 171,121,209 unique mutations and 1,078,774 non-silent mutations. This whole-genome resource has been made available in the NIMH Data Archive ( nda.nih.gov ) and accompanying deep demographic and phenotypic descriptions are available at the NeuroBioBank Portal ( neurobiobank.nih.gov ). To illustrate an application of this resource, we replicated the strong association observed in previous studies between pathogenic CAG repeat expansions in the HTT gene with the clinical diagnosis of Huntington’s disease.
Open AccessThe NeuroBioBank Whole-Genome Catalog: Sequencing from human brain donors with central nervous system disorders
Central nervous system diseases are a prevailing cause of morbidity and mortality worldwide, and are influenced by environmental and biological factors including genetic risk. Here we generated genome-wide genetic data on a large cohort of brain tissue donors with in-depth clinical and neuropathological phenotyping, allowing for broad investigations into the risk and mechanisms of these neurological, neurodevelopmental, and psychiatric conditions. This resource consists of 9,663 donors with array-based genotyping and 9,543 donors with whole-genome sequencing completed. The clinical diagnoses of these donors include 148 central nervous system diseases clustered in 15 broad categories by ICD-10 coding. These donors were collected by six repositories comprising the NIH NeuroBioBank, with an average participant age of 60 years. While primarily older individuals of European descent, the cohort also contains younger donors and individuals from non-European backgrounds. Variants detected by Whole-Genome Sequencing (WGS) were called genome-wide and annotated to describe their functional impact, resulting in 171,121,209 unique mutations and 1,078,774 non-silent mutations. This whole-genome resource has been made available in the NIMH Data Archive ( nda.nih.gov ) and accompanying deep demographic and phenotypic descriptions are available at the NeuroBioBank Portal ( neurobiobank.nih.gov ). To illustrate an application of this resource, we replicated the strong association observed in previous studies between pathogenic CAG repeat expansions in the HTT gene with the clinical diagnosis of Huntington’s disease.
- Open Access
- 25 April 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (5) , 114112
Focal clusters of peri-synaptic matrix contribute to activity-dependent plasticity and memory in mice
- 25 April 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (5) , 114112
Open AccessFocal clusters of peri-synaptic matrix contribute to activity-dependent plasticity and memory in mice
- Top Cited PapersOpen Access
- 6 March 2024
- Published by Springer Nature in Nature
- Vol. 627 (8004) , 604-611
A concerted neuron–astrocyte program declines in ageing and schizophrenia
Human brains vary across people and over time; such variation is not yet understood in cellular terms. Here we describe a relationship between people’s cortical neurons and cortical astrocytes. We used single-nucleus RNA sequencing to analyse the prefrontal cortex of 191 human donors aged 22–97 years, including healthy individuals and people with schizophrenia. Latent-factor analysis of these data revealed that, in people whose cortical neurons more strongly expressed genes encoding synaptic components, cortical astrocytes more strongly expressed distinct genes with synaptic functions and genes for synthesizing cholesterol, an astrocyte-supplied component of synaptic membranes. We call this relationship the synaptic neuron and astrocyte program (SNAP). In schizophrenia and ageing—two conditions that involve declines in cognitive flexibility and plasticity1,2—cells divested from SNAP: astrocytes, glutamatergic (excitatory) neurons and GABAergic (inhibitory) neurons all showed reduced SNAP expression to corresponding degrees. The distinct astrocytic and neuronal components of SNAP both involved genes in which genetic risk factors for schizophrenia were strongly concentrated. SNAP, which varies quantitatively even among healthy people of similar age, may underlie many aspects of normal human interindividual differences and may be an important point of convergence for multiple kinds of pathophysiology.
- 6 March 2024
- Published by Springer Nature in Nature
- Vol. 627 (8004) , 604-611
Top Cited PapersOpen AccessA concerted neuron–astrocyte program declines in ageing and schizophrenia
Human brains vary across people and over time; such variation is not yet understood in cellular terms. Here we describe a relationship between people’s cortical neurons and cortical astrocytes. We used single-nucleus RNA sequencing to analyse the prefrontal cortex of 191 human donors aged 22–97 years, including healthy individuals and people with schizophrenia. Latent-factor analysis of these data revealed that, in people whose cortical neurons more strongly expressed genes encoding synaptic components, cortical astrocytes more strongly expressed distinct genes with synaptic functions and genes for synthesizing cholesterol, an astrocyte-supplied component of synaptic membranes. We call this relationship the synaptic neuron and astrocyte program (SNAP). In schizophrenia and ageing—two conditions that involve declines in cognitive flexibility and plasticity1,2—cells divested from SNAP: astrocytes, glutamatergic (excitatory) neurons and GABAergic (inhibitory) neurons all showed reduced SNAP expression to corresponding degrees. The distinct astrocytic and neuronal components of SNAP both involved genes in which genetic risk factors for schizophrenia were strongly concentrated. SNAP, which varies quantitatively even among healthy people of similar age, may underlie many aspects of normal human interindividual differences and may be an important point of convergence for multiple kinds of pathophysiology.
- Open Access
Concerted neuron-astrocyte gene expression declines in aging and schizophrenia
Human brains vary across people and over time; such variation is not yet understood in cellular terms. Here we describe a striking relationship between people’s cortical neurons and cortical astrocytes. We used single-nucleus RNA-seq to analyze the prefrontal cortex of 191 human donors ages 22-97 years, including healthy individuals and persons with schizophrenia. Latent-factor analysis of these data revealed that in persons whose cortical neurons more strongly expressed genes for synaptic components, cortical astrocytes more strongly expressed distinct genes with synaptic functions and genes for synthesizing cholesterol, an astrocyte-supplied component of synaptic membranes. We call this relationship the Synaptic Neuron- and-Astrocyte Program (SNAP). In schizophrenia and aging – two conditions that involve declines in cognitive flexibility and plasticity 1,2 – cells had divested from SNAP: astrocytes, glutamatergic (excitatory) neurons, and GABAergic (inhibitory) neurons all reduced SNAP expression to corresponding degrees. The distinct astrocytic and neuronal components of SNAP both involved genes in which genetic risk factors for schizophrenia were strongly concentrated. SNAP, which varies quantitatively even among healthy persons of similar age, may underlie many aspects of normal human interindividual differences and be an important point of convergence for multiple kinds of pathophysiology.
Open AccessConcerted neuron-astrocyte gene expression declines in aging and schizophrenia
Human brains vary across people and over time; such variation is not yet understood in cellular terms. Here we describe a striking relationship between people’s cortical neurons and cortical astrocytes. We used single-nucleus RNA-seq to analyze the prefrontal cortex of 191 human donors ages 22-97 years, including healthy individuals and persons with schizophrenia. Latent-factor analysis of these data revealed that in persons whose cortical neurons more strongly expressed genes for synaptic components, cortical astrocytes more strongly expressed distinct genes with synaptic functions and genes for synthesizing cholesterol, an astrocyte-supplied component of synaptic membranes. We call this relationship the Synaptic Neuron- and-Astrocyte Program (SNAP). In schizophrenia and aging – two conditions that involve declines in cognitive flexibility and plasticity 1,2 – cells had divested from SNAP: astrocytes, glutamatergic (excitatory) neurons, and GABAergic (inhibitory) neurons all reduced SNAP expression to corresponding degrees. The distinct astrocytic and neuronal components of SNAP both involved genes in which genetic risk factors for schizophrenia were strongly concentrated. SNAP, which varies quantitatively even among healthy persons of similar age, may underlie many aspects of normal human interindividual differences and be an important point of convergence for multiple kinds of pathophysiology.